Abstract：Objective: To study the respective effects of high phosphorus or high parathyroid hormone levels on smooth muscle cell calcification. Methods: Human thoracic aortic vascular smooth muscle cells (VSMC) were cultured in vitro for 14 days and divided into control group, high phosphorus group (2.6 mmol/L), high parathyroid hormone (parathyroid hormone 1-34, PTH1-34) group a (PTH1-34 concentration 10-11 mol/L), high parathyroid hormone (parathyroid hormone 1-34, PTH1-34) group b (PTH1-34 concentration 10-10 mol/L), and observed in respect of cellular calcium salt deposition after alizarin red staining; real-time quantitative PCR and western blotting were used to detect the gene and protein expression of bone morphogenetic protein 2 (BMP-2) and Runt-related transcription factor 2 (Runx-2). The intracellular calcium content of each group was determined by applying the intracellular calcium content kit. Resulst: Calcification of vascular smooth muscle cells in the high phosphorus group was detected by alizarin red staining, and expression of calcification proteins BMP-2 and Runx-2 was significantly increased by western blotting. Calcification of vascular smooth muscle cells cultured in the high parathyroid hormone group was not detected by alizarin red staining, and BMP-2 and Runx-2 expression in vascular smooth muscle cells in the high parathyroid hormone group was not increased by real-time quantitative PCR and western blotting compared with the control group. expression did not increase compared with the control group. The intracellular calcium content of cells in the high phosphorus group was significantly higher than that of the control group, and the intracellular calcium content of cells in the high parathyroid hormone a and b groups did not differ from that of normal control cells (P>0.05). Conclusion: The calcification of VSMCs was induced merely by high phosphorus, However,PTH stimulation for 14 days failed to calcify vascular smooth muscle cells.
[1] Pieter Evenepoel,Britt Opdebeeck,Karel David,et al.Bone-vascular axis in chronic kidney disease[J].Adv Chronic Kidney Dis,2019,26(6):472-483. [2] Mario Cozzolino,Paola Ciceri,Andrea Galassi,et al.The key role of phosphate on vascular calcification[J].Toxins(Basel),2019,11(4):213. [3] Natalia Carrillo-Lopez,Sara Panizo,Cristina Alonso-Montes,et al.High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease[J].Nephrol Dial Transplant,2019,34(6):934-941. [4] Andrew L Durham,Mei Y Speer,Marta Scatena,et al.Role of smooth muscle cells in vascular calcification:implications in atherosclerosis and arterial stiffness[J].Cardiovasc Res,2018,114(4):590-600. [5] Jakob Voelkl,Florian Lang,Kai-Uwe Eckardt,et al.Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia[J].Cell Mol Life Sci,2019,76(11):2077-2091. [6] Trang T D Luong,Nadeshda Schelski,Beate Boehme,et al.Fibulin-3 attenuates phosphate induced vascular smooth muscle cell calcification by inhibition of oxidative stress[J].Cell Physiol Biochem,2018,46(4):1305-1316. [7] Arvind Ponnusamy,Smeeta Sinha,Gareth D Hyde,et al.FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis[J].PLoS One,2018,13(4):e0196232. [8] 金成,程歆琦,禹松林,等.中国人群血清甲状旁腺素水平[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(3):233-239. [9] Fujii H.Association between parathyroid hormone and cardiovascular disease[J].Ther Apher Dial,2018,22(3):236-241.
2022, Vol. 28 
冀公网安备13080202000677号